允许性低喂养对重症患者的疗效:一项更新的系统评价与试验序贯Meta分析
该研究为更新的系统评价与试验序贯Meta分析,检索7个数据库,纳入23项随机对照试验、共11444例重症患者。结果显示,允许性低喂养组与对照组相比,ICU死亡率降低(RR=0.90;95%CI [0.81, 0.99];P=0.02;I²=0%),胃肠道不良事件发生率降低(RR=0.79;95%CI [0.69, 0.90];P=0.0003;I²=56%),机械通气时间缩短(MD=-1.85天;95%CI [-3.44, -0.27];P=0.02;I²=0%);总体死亡率、住院死亡率、住院时间及总体感染发生率无显著差异。作者认为,由于样本量和患者异质性,结论仍需设计良好的大规模随机对照试验验证。
要点
- 纳入23项随机对照试验、11444例重症患者,允许性低喂养组ICU死亡率低于对照组(RR=0.90;95%CI [0.81, 0.99];P=0.02;I²=0%)。
- 允许性低喂养组胃肠道不良事件发生率低于对照组(RR=0.79;95%CI [0.69, 0.90];P=0.0003;I²=56%)。
- 允许性低喂养组机械通气时间较对照组缩短(MD=-1.85天;95%CI [-3.44, -0.27];P=0.02;I²=0%)。
- 总体死亡率、住院死亡率、住院时间及总体感染发生率在两组间无显著差异。
- 作者认为,由于样本量和患者异质性,上述结论仍需设计良好的大规模随机对照试验验证。
适用人群与场景
- 入住重症监护病房(ICU)的重症患者,来自23项随机对照试验共11444例。
研究设计与关键结果
- 研究设计:更新的系统评价与试验序贯Meta分析,检索PubMed、Embase、Web of Science、中国知网、万方、中国生物医学文献数据库和Cochrane Library共7个数据库,纳入随机对照试验,采用修订版Cochrane偏倚风险工具(ROB 2)评估偏倚风险,使用RevMan软件进行数据合成,对总体死亡率和ICU死亡率进行试验序贯分析。
- 共纳入23项随机对照试验、11444例重症患者。
- 总体死亡率、住院死亡率、住院时间和总体感染发生率在允许性低喂养组与对照组之间无显著差异。
- 与对照组相比,允许性低喂养组ICU死亡率降低(RR=0.90;95%CI [0.81, 0.99];P=0.02;I²=0%)。
- 与对照组相比,允许性低喂养组胃肠道不良事件发生率降低(RR=0.79;95%CI [0.69, 0.90];P=0.0003;I²=56%)。
- 与对照组相比,允许性低喂养组机械通气时间缩短(MD=-1.85天;95%CI [-3.44, -0.27];P=0.02;I²=0%)。
证据类型、等级与局限
- 证据类型:系统评价与试验序贯Meta分析,仅纳入随机对照试验,采用修订版Cochrane偏倚风险工具(ROB 2)评估偏倚风险。
- 局限:作者指出,由于样本量和患者异质性,结论仍需设计良好的大规模随机对照试验验证。
对床旁实践的改变
- 作者认为,允许性低喂养可能降低重症患者ICU死亡率并有助于缩短机械通气时间,但总体死亡率未改善。
- 作者认为,由于样本量和患者异质性,该结论仍需设计良好的大规模随机对照试验验证。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Our previous study in 2011 concluded that permissive underfeeding may improve outcomes in patients receiving parenteral nutrition therapy. This conclusion was tentative, given the small sample size. We conducted the present systematic review and trial sequential meta-analysis to update the status of permissive underfeeding in patients who were admitted to the intensive care unit (ICU).
METHODS: Seven databases were searched: PubMed, Embase, Web of Science, China National Knowledge Infrastructure, Wanfang, Chinese Biomedical Literature Database, and Cochrane Library. Randomized controlled trials (RCTs) were included. The Revised Cochrane risk-of-bias tool (ROB 2) was used to assess the risk of bias in the enrolled trials. RevMan software was used for data synthesis. Trial sequential analyses (TSA) of overall and ICU mortalities were performed.
RESULTS: Twenty-three RCTs involving 11,444 critically ill patients were included. There were no significant differences in overall mortality, hospital mortality, length of hospital stays, and incidence of overall infection. Compared with the control group, permissive underfeeding significantly reduced ICU mortality (risk ratio [RR] = 0.90; 95% confidence interval [CI], [0.81, 0.99]; P = 0.02; I2 = 0%), and the incidence of gastrointestinal adverse events decreased (RR = 0.79; 95% CI, [0.69, 0.90]; P = 0.0003; I2 = 56%). Furthermore, mechanical ventilation duration was reduced (mean difference (MD) = - 1.85 days; 95% CI, [- 3.44, - 0.27]; P = 0.02; I2 = 0%).
CONCLUSIONS: Permissive underfeeding may reduce ICU mortality in critically ill patients and help to shorten mechanical ventilation duration, but the overall mortality is not improved. Owing to the sample size and patient heterogeneity, the conclusions still need to be verified by well-designed, large-scale RCTs. Trial Registration The protocol for our meta-analysis and systematic review was registered and recorded in PROSPERO (registration no. CRD42023451308). Registered 14 August 2023.
参考来源
- Yue HY, Peng W, Zeng J, et al. Efficacy of permissive underfeeding for critically ill patients: an updated systematic review and trial sequential meta-analysis. J Intensive Care. 2024. PMID: 38254228. doi:10.1186/s40560-024-00717-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。